Bambusa Therapeutics
Cambridge, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $90M
Overview
Creating biologic therapies to modulate the immune system for autoimmune and inflammatory diseases.
Immunology
Technology Platform
A biologics discovery platform focused on identifying and validating novel targets in immune signaling pathways for autoimmune and inflammatory diseases.
Funding History
1Total raised:$90M
Series A$90M
Opportunities
Addressing significant unmet needs in autoimmune diseases with potentially safer, more effective targeted biologics.
Risk Factors
High competition and the challenge of demonstrating clinical superiority over existing standard-of-care treatments.
Competitive Landscape
Enters a crowded immunology market with many established biologic drugs and numerous competitors developing next-generation therapies.